Biomarkers Development and Testing Capabilities
Biomarkers improve trials through better stratification, faster decisions, and smoother approvals. MICS offers full biomarker testing to support your programs.
Biomarkers services
Accelerate Your Clinical Development
with Actionable Biomarker Insights
Biomarkers are transforming how pharma market designs and execute clinical trials, driving better patient stratification, faster decision-making, and more efficient pathways to regulatory approval. At Medicover Integrated Clinical Services (MICS), we offer a comprehensive portfolio of biomarker testing solutions that enable you to select the right biomarkers, integrate them seamlessly into your protocols, and generate robust, data-driven evidence for your clinical programs.
Target, mechanistic, and disease-level analysis
Contact our subject-matter expert
sales.imgm@medicover.com
Pharmacodynamic
Contact our subject-matter expert
sales.imgm@medicover.com
Cell and gene therapy
Contact our subject-matter expert
sales.imgm@medicover.com
Protein / peptide therapeutics
Contact our subject-matter expert
sales.imgm@medicover.com
Ligand binding assays
Contact our subject-matter expert
sales.imgm@medicover.com
Multiplexing
Contact our subject-matter expert
sales.imgm@medicover.com
Method development / qualification
Contact our subject-matter expert
sales.imgm@medicover.com
Partial or full validation
Contact our subject-matter expert
sales.imgm@medicover.com
Assay transfer and/or optimization
Contact our subject-matter expert
sales.imgm@medicover.com
Preclinical and clinical sample analysis
Contact our subject-matter expert
sales.imgm@medicover.com
Comprehensive Testing Portfolio
Our integrated portfolio of biomarker assays covers a wide range of therapeutic areas and analytical platforms, ensuring that you have access to the right test at the right time. From established clinical biomarkers to cutting-edge genomic and proteomic assays, we deliver both breadth and depth to address your evolving clinical research needs:
Genomic & Molecular Testing:
- Next-Generation Sequencing (NGS) panels for oncology and rare diseases
- qPCR-based assays for gene expression and mutation analysis
- Microarray platforms for comprehensive genomic profiling
Proteomic & Immunoassays
- Multiplex immunoassays and ELISAs for targeted protein quantification
- Protein profiling technologies to characterize disease-related biomarkers
Imaging & Digital Pathology:
- Quantitative imaging endpoints for objective patient assessment
- Digital pathology for enhanced diagnostic accuracy and efficiency
Biomarker and Molecular Analysis Platforms
Our laboratories are equipped with advanced technologies to support complex biomarker studies, genomic research, and molecular diagnostics. We focus on platforms that bring high sensitivity, reproducibility, and scalability for clinical trial needs.
- NovaSeqX (Illumina) – state-of-the-art next-generation sequencing.
- SeqStudio Genetic Analyzer (Applied Biosystems) – trusted for Sanger sequencing.
- QIAsymphony (Qiagen) – automated high-throughput nucleic acid extraction.
- Multiple validated real-time PCR systems (Roche, Agilent, Seegene).
- Meso QuickPlex SQ 1300 (Meso Scale Diagnostics) – ultra-sensitive electrochemiluminescence detection.
- Luminex 200 (Millipore) – established multiplex bead-based assays.
- Phadia 1000 (Thermo Fisher) – advanced platform for allergy and autoimmunity.
- Immulite (Siemens Healthineers) – broad chemiluminescent immunoassay menu.
- ICP-MS and GC-MS/MS – precise analysis of trace elements and metabolites.
- Cell & Immune Profiling
- FACSLyric Flow Cytometer (BD, 10-colour) – comprehensive immune cell analysis.
Our Advantages
Expert guidance, advanced technologies, and proven results in biomarker testing.
Regulatory Guidance and Alignment
We don’t just deliver test results – we provide the scientific consultation and regulatory guidance needed to leverage your data effectively. Our biomarker specialists work closely with you to:
- Identify the most relevant biomarkers to enhance trial design and patient selection
- Ensure alignment with global regulatory standards (GLP, GCP, CAP/CLIA) and support companion diagnostic development
- Streamline data interpretation, enabling faster, evidence-based decisions
Advanced Technologies & Secure Data Management
MICS combines cutting-edge instrumentation with automated workflows to deliver high-quality, reproducible results at scale. From high-throughput sequencers and mass spectrometry platforms to integrated Laboratory Information Management Systems (LIMS) and secure digital infrastructures, we ensure:
- Rapid turnaround times for critical data points
- Consistent, validated processes that meet international quality benchmarks
- Real-time access to results and data analytics tools for informed decision-making
Success Stories: Driving Efficiency & Outcomes
Our biomarker testing capabilities have helped clients improve trial outcomes and accelerate time-to-market:
- Reduced Screen Failures: Targeted biomarker panels guided patient selection, cutting screen-failure rates by up to 35%.
- Companion Diagnostic Development: Co-development of a validated assay streamlined regulatory submission and supported faster commercial launch
Ready to Transform Your Clinical Trials?
Take the next step in enhancing your biomarker strategy. Contact our experts today to discuss your project needs and learn how Medicover MICS can provide the biomarker solutions that help you achieve your clinical and commercial goals.
We respond within 24 hours.